Compugen Ltd.

Compugen to Release Third Quarter 2026 Results on Monday, November 9, 2026

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered…